Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2013

To view an abstract, select an author from the vertical list on the left.

2013 Grants - Mirica

Bifunctional Chemical Agents as Theranostic Tools for Abeta Aggregation

Liviu M. Mirica, Ph.D.
Washington University in St. Louis
St. Louis, Missouri

2013 New Investigator Research Grant

Beta-amyloid (also known as Abeta) is a protein fragment that clumps into amyloid plaques, one of the characteristic features of Alzheimer's disease. Beta-amyloid also forms smaller clumps known as oligomers, which are now believed to be the form of beta-amyloid that is most toxic to nerve cells. Some evidence suggests that beta-amyloid oligomers are stabilized by certain metal compounds, making the oligomers more toxic.

Liviu M. Mirica, Ph.D., and colleagues have proposed a series of studies with the goal of developing a single drug that performs two functions: (1) binds to beta-amyloid thereby reducing its ability to form clumps, and (2) binds to metals to reduce their ability to increase the toxicity of beta-amyloid.

Dr. Mirica and colleagues also believe that such a drug, because it binds beta-amyloid and metals at the same time, could be used to visualize beta-amyloid in the brain using existing imaging techniques. These studies could lead to the development of new ways to diagnose Alzheimer's disease, as well as potential new ways to slow or prevent disease progression.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.